Seeking Alpha

Cell Therapeutics (CTIC +0.7%) has regained compliance with Nasdaq's minimum bid price rule. (PR)

Cell Therapeutics (CTIC +0.7%) has regained compliance with Nasdaq's minimum bid price rule. (PR)
Comments (2)
  • This company is a joke. The only thing they know is to how to hurt shareholders by Reverse Splits.
    19 Sep 2012, 08:47 AM Reply Like
  • All of these pharma companies are a crap shoot but if one hits, boom, they go wild. Which companies have the most at phase 3 are the ones to watch.
    24 Sep 2012, 12:26 PM Reply Like
DJIA (DIA) S&P 500 (SPY)